Shree Ganesh Bio‑Tech (India) acquires 86.48  lakh shares of Suncare Traders, stake now 1.89%

What Suncare Traders disclosed

On 24 June 2026, Suncare Traders Ltd filed a disclosure with BSE under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing informs that Shree Ganesh Bio‑Tech (India) Limited, acting alone and not as a promoter, has acquired a block of voting shares in Suncare Traders during the period 1 April 2026 to 22 June 2026.

The filing does not contain any narrative beyond the statutory tables, but the numbers allow a clear picture of the size and timing of the transaction.

Details of the share acquisition

The acquisition represents a modest increase in the acquirer’s exposure to Suncare Traders. The filing records the number of shares bought and the resulting holding, but does not disclose the consideration paid, nor the exact mode (open‑market, off‑market, etc.).

Shareholding before and after the transaction

Before the acquisition, Shree Ganesh Bio‑Tech held 1,34,58,166 voting shares, equivalent to 5.28 % of Suncare Traders’ diluted voting capital. After disposing of 86,48,166 shares (as reflected in the table), the remaining holding fell to 48,10,000 shares, or 1.89 % of the total.

The reduction in percentage ownership suggests that the transaction was a partial disposal rather than a net increase in stake, despite the heading “acquisition”. The filing format captures both the shares bought/sold and the resulting holding, which in this case shows a net decline.

Key facts at a glance

Why this matters for investors

The filing is a statutory requirement that informs the market about any substantial change in shareholding of a listed entity. For shareholders of Suncare Traders, the key implications are:

• Transparency of ownership changes – The disclosure confirms that a non‑promoter entity has altered its stake, which may affect voting dynamics in future shareholder meetings.
• Potential impact on control – Although the post‑transaction holding is only 1.89 %, the reduction from 5.28 % indicates that the acquirer is moving away from a material influence position.
• No immediate dilution – The transaction involves the transfer of existing shares; there is no issuance of new shares, so existing shareholders’ proportional ownership is unchanged.
• Regulatory compliance – By filing under Regulation 29(2), Suncare Traders complies with SEBI’s takeover code, ensuring that the market receives timely information.

Investors should note that the filing does not disclose the price paid, the strategic rationale, or any future plans of the acquirer. Those aspects remain outside the scope of the statutory disclosure.

Conclusion

Suncare Traders Ltd disclosed that Shree Ganesh Bio‑Tech (India) Ltd bought 86.48  lakh voting shares between 1 April and 22 June 2026, leaving the acquirer with a residual holding of 48.10  lakh shares, or 1.89 % of the company’s equity. The transaction does not involve new share issuance and the acquirer is not a promoter. The filing satisfies SEBI’s requirement for notifying substantial shareholding changes, but it provides no insight into the commercial motives or the price paid. Further updates, if any, will be communicated through subsequent regulatory filings.